Jump Financial, LLC Avadel Pharmaceuticals PLC Transaction History

Jump Financial, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$12.55 - $17.22 $1.33 Million - $1.83 Million	106,088 Added 532.78%	126,000 $2.13 Million
Q4 2023 Oct 21, 2024	SELL	$9.64 - $14.59 $324,472 - $491,084	-33,659 Reduced 62.83%	19,912 $281,000
Q4 2023 Feb 07, 2024	SELL	$9.64 - $14.59 $324,472 - $491,084	-33,659 Reduced 62.83%	19,912 $281,000
Q3 2023 Oct 21, 2024	BUY	$10.3 - $15.99 $551,781 - $856,600	53,571 New	53,571 $551,000
Q3 2023 Nov 07, 2023	BUY	$10.3 - $15.99 $551,781 - $856,600	53,571 New	53,571 $551,000
Q2 2022 Aug 09, 2022	BUY	$1.07 - $6.95 $26,857 - $174,445	25,100 Added 80.45%	56,300 $137,000
Q1 2022 May 12, 2022	BUY	$5.46 - $8.29 $78,607 - $119,351	14,397 Added 85.68%	31,200 $213,000
Q4 2021 Feb 10, 2022	BUY	$7.34 - $11.18 $123,334 - $187,857	16,803 New	16,803 $136,000
Q3 2021 Nov 12, 2021	SELL	$6.49 - $9.91 $88,990 - $135,885	-13,712 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$6.73 - $9.05 $92,281 - $124,093	13,712 New	13,712 $92,000
Q1 2021 May 17, 2021	SELL	$6.61 - $10.07 $77,693 - $118,362	-11,754 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$5.03 - $7.95 $5,346 - $8,450	1,063 Added 9.94%	11,754 $79,000
Q3 2020 Nov 13, 2020	BUY	$5.02 - $8.98 $53,668 - $96,005	10,691 New	10,691 $54,000

1.07M

Ticker AVDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 60,581,300
Market Cap $661M
Description
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.